Old Web
English
Sign In
Acemap
>
authorDetail
>
Hiromi Okabe
Hiromi Okabe
Daiichi Sankyo
Neuraminidase inhibitor
Laninamivir
Medicine
Pharmacokinetics
Pharmacology
5
Papers
102
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (5)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Alpha-Amylase Inhibitor, CS-1036 Binds to Serum Amylase in a Concentration-Dependent and Saturable Manner
2014
Drug Metabolism and Disposition
Tomohiro Honda
Yoko Kaneno-Urasaki
Takashi Ito
Takako Kimura
Nobuko Matsushima
Hiromi Okabe
Atsushi Yamasaki
Takashi Izumi
Show All
Source
Cite
Save
Citations (2)
Intrapulmonary Distribution and Pharmacokinetics of Laninamivir, a Neuraminidase Inhibitor, after a Single Inhaled Administration of Its Prodrug, Laninamivir Octanoate, in Healthy Volunteers
2012
Antimicrobial Agents and Chemotherapy
Hitoshi Ishizuka
Kaoru Toyama
Satoshi Yoshiba
Hiromi Okabe
Hidetoshi Furuie
Show All
Source
Cite
Save
Citations (27)
Assessment of the Effects of Renal Impairment on the Pharmacokinetic Profile of Laninamivir, a Novel Neuraminidase Inhibitor, After a Single Inhaled Dose of Its Prodrug, CS‐8958
2011
The Journal of Clinical Pharmacology
Hitoshi Ishizuka
Satoshi Yoshiba
Kazutaka Yoshihara
Hiromi Okabe
Show All
Source
Cite
Save
Citations (14)
Pharmacokinetics of Laninamivir after a Single Administration of its Prodrug, Laninamivir Octanoate, a Long-Acting Neuraminidase Inhibitor, Using an Easy-to-Use Inhaler in Healthy Volunteers
2011
Journal of Bioequivalence & Bioavailability
Satoshi Yoshiba
Hiromi Okabe
Hitoshi Ishizuka
Show All
Source
Cite
Save
Citations (10)
Clinical Pharmacokinetics of Laninamivir, a Novel Long‐Acting Neuraminidase Inhibitor, After Single and Multiple Inhaled Doses of Its Prodrug, CS‐8958, in Healthy Male Volunteers
2010
The Journal of Clinical Pharmacology
Hitoshi Ishizuka
Satoshi Yoshiba
Hiromi Okabe
Kazutaka Yoshihara
Show All
Source
Cite
Save
Citations (49)
1